Literature DB >> 17056336

Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study).

Showkat A Haji1, Rifat Eralp Ulusoy, Dharmendrakumar A Patel, Sathanur R Srinivasan, Wei Chen, Patrice Delafontaine, Gerald S Berenson.   

Abstract

Left ventricular (LV) dilatation may be an early sign of cardiac decompensation progressing to LV dysfunction. Determinants of LV dilatation in young asymptomatic adults are unknown. Five hundred six asymptomatic subjects (mean age 32 +/- 3 years) enrolled in the Bogalusa Heart Study underwent echocardiographic examination. LV dilatation (LV end-diastolic diameter >5.5 cm) as measured by M-mode echocardiography was found in 31 subjects (6%). Subjects with LV dilatation had greater body mass indexes (32 +/- 9 vs 27 +/- 6 kg/m2, p <0.0001), systolic (119 +/- 15 vs 112 +/- 12 mm Hg, p = 0.007) and diastolic (79 +/- 12 vs 75 +/- 9 mm Hg, p = 0.04) blood pressures, and LV mass (230 +/- 50 vs 123 +/- 39 g, p <0.0001). Age, gender, race, and metabolic parameters (glucose, insulin, and lipoprotein levels) did not differ significantly between the subjects with and without LV dilatation. After correction for age, gender, and race differences, adulthood obesity (body mass index >30 kg/m2) was associated with a threefold odds ratio (2.9, 95% confidence interval 1.4 to 6.1), and hypertension (defined as per the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure) was also associated with a threefold odds ratio (3.0, 95% confidence interval 1.2 to 7.1) for an increased incidence of LV dilatation. There was an incremental increase in LV end-diastolic dimension depending on the presence of hypertension or obesity, and subjects with obesity and hypertension in adulthood had the greatest degree of LV end-diastolic dimensions. In multiple regression analyses, body mass index in childhood was the only significant predictor of LV dilatation in adulthood (odds ratio 1.47, 95% confidence interval 1.03 to 2.09). In conclusion, obesity beginning in childhood and obesity and hypertension in young adulthood are predictors of LV dilatation in an otherwise healthy young adult population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056336      PMCID: PMC3228635          DOI: 10.1016/j.amjcard.2006.05.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study.

Authors:  Sathanur R Srinivasan; Leann Myers; Gerald S Berenson
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

2.  Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

Authors:  R S Vasan; M G Larson; E J Benjamin; J C Evans; D Levy
Journal:  N Engl J Med       Date:  1997-05-08       Impact factor: 91.245

3.  Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study.

Authors:  Xiangrong Li; Shengxu Li; Eralp Ulusoy; Wei Chen; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

4.  Left ventricular dilatation. Prognostic value in severe left ventricular dysfunction secondary to coronary artery disease.

Authors:  P F Nestico; A H Hakki; A S Iskandrian
Journal:  Chest       Date:  1985-08       Impact factor: 9.410

5.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

6.  Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents.

Authors:  D P Williams; S B Going; T G Lohman; D W Harsha; S R Srinivasan; L S Webber; G S Berenson
Journal:  Am J Public Health       Date:  1992-03       Impact factor: 9.308

7.  Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors.

Authors:  P Gaudron; C Eilles; I Kugler; G Ertl
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

8.  Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study).

Authors:  M Galderisi; M S Lauer; D Levy
Journal:  Am J Cardiol       Date:  1992-10-15       Impact factor: 2.778

9.  Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study).

Authors:  M S Lauer; J C Evans; D Levy
Journal:  Am J Cardiol       Date:  1992-11-01       Impact factor: 2.778

10.  Racial differences of parameters associated with blood pressure levels in children--the Bogalusa heart study.

Authors:  G S Berenson; A W Voors; L S Webber; E R Dalferes; D W Harsha
Journal:  Metabolism       Date:  1979-12       Impact factor: 8.694

View more
  11 in total

1.  Left ventricle diastolic dysfunction in obese patients with newly diagnosed arterial hypertension.

Authors:  Viktor Persic; Alen Ruzic; Bojan Miletic; Sanja Balen; Zeljko Jovanovic; Aleksandar Vcev; Sanjin Racki; Bozidar Vujicic
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 2.  Childhood obesity and cardiovascular disease: links and prevention strategies.

Authors:  Kristen J Nadeau; David M Maahs; Stephen R Daniels; Robert H Eckel
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

3.  Left ventricular volume: an optimal parameter to detect systolic dysfunction on prospectively triggered 64-multidetector row computed tomography: another step towards reducing radiation exposure.

Authors:  Mohit Gupta; Yalcin Hacioglu; Jigar Kadakia; Naser Ahmadi; Yanlin Gao; Song S Mao; Matthew J Budoff
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-10       Impact factor: 2.357

4.  Radiological Cardiothoracic Ratio as a Potential Marker of Left Ventricular Hypertrophy Assessed by Echocardiography.

Authors:  Krystian Truszkiewicz; Piotr Macek; Małgorzata Poręba; Rafał Poręba; Paweł Gać
Journal:  Radiol Res Pract       Date:  2022-06-15

5.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

6.  Factor analysis of markers of inflammation and oxidation and echocardiographic findings in children with a positive family history of premature coronary heart disease.

Authors:  Roya Kelishadi; Mohammadreza Sabri; Neda Motamedi; Mohammad Arash Ramezani
Journal:  Pediatr Cardiol       Date:  2009-03-26       Impact factor: 1.655

7.  Obesity and cardiovascular risk in children and adolescents.

Authors:  Manu Raj
Journal:  Indian J Endocrinol Metab       Date:  2012-01

Review 8.  Determinants, consequences and prevention of childhood overweight and obesity: An Indian context.

Authors:  Harish Ranjani; Rajendra Pradeepa; T S Mehreen; Ranjit Mohan Anjana; Krishnan Anand; Renu Garg; Viswanathan Mohan
Journal:  Indian J Endocrinol Metab       Date:  2014-11

9.  End-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study.

Authors:  Paul Muntner; Asghar Arshad; Stephen A Morse; Dharmendrakumar A Patel; Pronabesh D Manapatra; Efrain Reisin; Erwin A Aguilar; Wei Chen; Sathanur Srinivasan; Gerald S Berenson
Journal:  BMC Nephrol       Date:  2009-12-02       Impact factor: 2.388

10.  Cardiovascular Risk Factors from Early Life Predict Future Adult Cardiac Structural and Functional Abnormalities: A Systematic Review of the Published Literature.

Authors:  Arjun K Ghosh; Darrel P Francis; Nishi Chaturvedi; Diana Kuh; Jamil Mayet; Alun D Hughes; Rebecca J Hardy
Journal:  J Cardiol Ther       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.